Repligen | Les Charges D'Exploitation



Operating Expenses Changement Date
Agilent USD 1.31B 12M 2025-01
Align Technology USD 848.16M 2.91M 2025-03
Bio Techne USD 249.61M 141K 2024-12
BioMarin Pharmaceutical USD 521.25M 64.65M 2025-03
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
Bruker USD 769.6M 145.9M 2025-03
Charles River Laboratories USD 909.5M 260.74M 2025-03
Danaher USD 4.46B 655M 2025-03
Dentsply International USD 816M 598M 2025-03
Exact Sciences USD 802.8M 786.98M 2025-03
General Electric USD 7.99B 732M 2025-03
Henry Schein USD 2.99B 43M 2025-03
Illumina USD 910M 19M 2025-03
IQVIA Holdings USD 3.34B 5M 2025-03
Mettler Toledo International USD 681.8M 48.78M 2025-03
Myriad Genetics USD 224.9M 24.7M 2025-03
Pfizer USD 10.05B 8.12B 2025-03
Repligen USD 162.59M 41.45M 2025-03
Revvity USD 592.53M 18.09M 2025-03
Standard Biotools USD 79.54M 2.85M 2024-12
Thermo Fisher Scientific USD 8.65B 731M 2025-03
Waters USD 509.96M 70.49M 2025-03
West Pharmaceutical Services USD 591M 1.8M 2025-03



Repligen Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.